Effects of Nurse-Led Stigma-Reduction Education in Epilepsy
ConditionEpilepsy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMuş Alparslan University
About this trial
This randomized controlled trial aims to evaluate the effect of a nurse-led, stigma-reduction-based epilepsy education program on perceived/internalized stigma, concealment of epilepsy, and self-management among adults with epilepsy.
Participants will be randomly assigned to an intervention group or a control group. The intervention group will receive a structured nurse-led education program consisting of four weekly sessions, each lasting approximately 45-60 minutes. The program will address epilepsy-related knowledge and misconceptions, stigma and self-stigma, disclosure and concealment of epilepsy, communication, medication adherence, seizure triggers, stress management, seizure diaries, and individual self-management planning. The control group will receive routine care without additional structured education during the study period.
Outcomes related to epilepsy stigma, concealment, and self-management will be assessed using validated measurement tools.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years or older
Diagnosed with epilepsy at least 6 months before enrollment
Able to communicate and participate in the education program without a cognitive or psychiatric condition that would prevent participation
Able to read and understand Turkish
Disqualifiers
Presence of a severe neurological disorder other than epilepsy
Presence of a serious psychiatric disorder
Advanced cognitive impairment or any condition preventing effective communication
Unable to attend the educational sessions regularly
Trial design
Design model
Parallel
Treatments tested in this trial
Nurse-Led Stigma-Reduction-Based Epilepsy Education
BehavioralParticipants in the intervention group will receive a structured nurse-led epilepsy education program focused on reducing stigma and supporting disease disclosure and self-management. The program will consist of four weekly sessions lasting approximately 45-60 minutes each. The sessions will address epilepsy-related knowledge and misconceptions, stigma and internalized stigma, concealment and disclosure of epilepsy, communication, medication adherence, seizure triggers, stress management, seizure diary use, and individualized self-management planning.
Treatment groups
65 Participants
are divided into 2 treatment groupsGroup A: Experimental groupsExperimental treatment 1 intervention
Group B: Routine Care Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Change in Epilepsy-Related Stigma
Epilepsy-related stigma will be assessed using the Epilepsy Stigma Scale. Total scores range from 25 to 100, with higher scores indicating greater epilepsy-related stigma (a worse outcome).
Time frame
Baseline and immediately after completion of the 4-week intervention2
Change in Concealment of Epilepsy
Concealment of epilepsy will be assessed using the Concealment of Epilepsy Scale. Total scores range from 15 to 75, with higher scores indicating greater concealment of epilepsy (a worse outcome).
Time frame
Baseline and immediately after completion of the 4-week intervention3
Change in Epilepsy Self-Management
Epilepsy self-management will be assessed using the Epilepsy Self-Management Scale. Total scores range from 38 to 190, with higher scores indicating more frequent use of epilepsy self-management behaviors (a better outcome).
Time frame
Baseline and immediately after completion of the 4-week interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Muş Alparslan University
Lead sponsor
Malatya Egitim Ve Arastirma Hastanesi
Collaborator
Source ClinicalTrials.gov